NCT00786318

Ziprasidone vs Standard Therapy for Agitated Patients in the ED

Prospective Double Blind Randomized Trial of Intramuscular Ziprasidone Compared With Standard Antipsychotic Therapy For The Treatment Of The Acutely Agitated Patient In The Emergency Department

• Status: Withdrawn
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: George Washington University · Academic / Other
• Sex: All
• Age: 18 Years – 100 Years
• Healthy volunteers: Not accepted

Summary

The primary objective is to determine if ziprasidone is superior to standard therapies in the emergency department treatment of the acutely agitated patient. The primary outcome will be the length of time taken until the patient is ready to be evaluated by the psychiatric service, or until a disposition is made.

Conditions

• Psychosis
• Agitation
• Delirium

Interventions

Type	Name	Description
DRUG	ziprasidone	ziprasidone 20mg IM
DRUG	Standard therapy	Haldol 5mg/ Ativan 2mg IM

Timeline

• Start date: 2008-09-01
• Primary completion: 2011-07-01
• Completion: 2011-07-01
• First posted: 2008-11-06
• Last updated: 2017-09-25

Locations

1 site across 1 country: United States